Geneva, March 23 -- International Clinical Trials Registry received information related to the study (EUCTR2026-000021-16-Outside-EU/EEA) titled 'A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents' on March 3.
Study Type: Interventional clinical trial of medicinal product
Study Design:
Controlled: yes Randomised: yes Open: no Single blind: no Double blind: yes Parallel group: no Cross over: no Other: no If controlled, specify comparator, Other Medicinial Product: no Placebo: yes Other: no Number of treatment arms in the trial: 2
Primary Sponsor: Instituto Butantan (Principal Sponsor in Brazil)
Condition:
healthy volunteers
active immunization for the prevention of Chiku...